Home Tags Drugs
Drugs Related Content
Researchers at University College London have found that COVID-19 mutations do not make the virus more likely to spread, as previously feared.
Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.
Dr Deborah Lee from Dr Fox Online Pharmacy sheds light on the role of plants in drugs and medicines in this absorbing analysis.
Sexual minorities, especially women, are more likely to have substance addictions due to discrimination, stress and childhood trauma.
Imperial College London are working on clinical trials of a kisspeptin drug that could treat PCOS, HA and other reproductive health problems.
Loneliness during lockdown is one of the most universal afflictions - when researchers studied young adults in the US, they found "alarming" levels of COVID-19 depression.
Over 350 million people suffer from arthritis pain globally, which means significant levels of opiates are used to manage the condition - but what if there was a less addictive treatment?
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
Though heart damage plays a role in how someone deals with COVID-19, researchers at the American Heart Association found that blood pressure medicines don't impact your chances.
A new study, led by researchers at Queen Mary University of London, uses novel biomarkers to predict patient responsiveness to rheumatoid arthritis treatment.
A new study found that it costs patients over $450 a year when they are prescribed the wrong drugs, making them twice as likely to go to hospital.
A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.
OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
In early 2016, I had reached a point in life where I needed to make a life-changing decision: Read the Savage Cabbage journey on OAG.
Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.
CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
Here, we learn all about the ‘opioid epidemic’ and how e-Learning for Healthcare’s e-PAIN programme is helping NHS staff to overcome it.
Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.